INCREASED ADHERENCE TO WARFARIN TREATMENT WITH TRAINING PROGRAMS IN PATIENTS WITH ATRIAL FIBRILLATION

INCREASED ADHERENCE TO WARFARIN TREATMENT WITH TRAINING PROGRAMS IN PATIENTS WITH ATRIAL FIBRILLATION

Purpose of the study: to assess the role of educational programs on anticoagulant therapy in patients with atrial fibrillation in increasing adherence to warfarin treatment.Material and methods: the study included patients with atrial fibrillation, divided into two groups: the main group (n=125) - p...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. D. Djishambaev, S. I. Khakimova, A. M. Shatenova, E. N. Murzalieva, D. A. Usupbaeva
Format:	Article
Language:	Russian
Published:	InterMedservice 2020-12-01
Series:	Евразийский Кардиологический Журнал
Subjects:	atrial fibrillation anticoagulant treatment inr ischemic stroke
Online Access:	https://www.heartj.asia/jour/article/view/6236
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

THE CONTROL OF INTERNATIONAL NORMALISED RATIO IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH WARFARIN IN OUTPATIENT AND HOSPITAL SETTINGS: DATA FROM RECVASA REGISTRIES
by: M. M. Loukianov, et al.
Published: (2018-03-01)

Health-Related Quality of Life among Atrial fibrillation Patients Undergoing Anticoagulation Therapy
by: Laila Mahmoud Matalqah, et al.
Published: (2022-02-01)

PHARMACODYNAMICS OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ACUTE PERIOD OF ISCHEMIC STROKE
by: V. I. Petrov, et al.
Published: (2021-01-01)

Anticoagulant therapy in patients with cardioembolic subtype of ischemic stroke and atrial fibrillation
by: E. A. Naryshkina, et al.
Published: (2025-06-01)

Prognosis of Patients With Ischemic Stroke With Prior Anticoagulant Therapy: Direct Oral Anticoagulants Versus Warfarin
by: Kyeong‐Hyeon Chun, et al.
Published: (2024-08-01)

Anticoagulant therapy for the prevention of recurrent stroke in patients with atrial fibrillation: a comprehensive risk management
by: V. A. Sorokoumov
Published: (2022-01-01)

Anticoagulant therapy in patients with ischemic stroke and atrial fibrillation (data from the registry of internal medicine departments of multidisciplinary hospitals of the North Caucasus Federal District)
by: Z. A. Alimova, et al.
Published: (2025-07-01)

Problems of selecting an anticoagulant for secondary stroke prevention in patients with atrial fibrillation
by: V. V. Gusev, et al.
Published: (2021-10-01)

Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation
by: Paula Tiili, et al.
Published: (2021-01-01)

Comparison between DOACs and warfarin for left atrial thrombus in atrial fibrillation patients
by: Akihiro Sunaga, et al.
Published: (2025-08-01)

Reasons for not prescribing anticoagulants in hospitalized patients with atrial fibrillation and high risk of stroke: what should be the optimal management tactics for these patients?
by: E. I. Baranova, et al.
Published: (2022-07-01)

Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient‐Level Meta‐Analysis From COMBINE AF
by: Linda S. Johnson, et al.
Published: (2024-09-01)

Wearable dynamic electrocardiogram monitor-based screening for atrial fibrillation in the community-dwelling elderly population
by: Lili Wei, et al.
Published: (2024-12-01)

Antiplatelet Use Prior to Anticoagulant Initiation in Patients With Atrial Fibrillation-Related Ischemic Stroke: An ELAN Trial Analysis
by: Alexandros A. Polymeris, et al.
Published: (2025-05-01)

Anticoagulation for Stroke Prevention in Patients with Atrial Fibrillation: A Review of the Literature and Current Guidelines
by: Vrinda Vyas, et al.
Published: (2025-06-01)

Outcomes of recurrent stroke in patients with atrial fibrillation according to presumed etiology
by: Bruno Bacellar Pedreira, et al.
Published: (2023-07-01)

Bleeding Risk Scores in Atrial Fibrillation: Helpful or Harmful?
by: Marissa K. Edmiston, et al.
Published: (2018-09-01)

Retrospective analysis of the prevalence of ischemic stroke and the appointment of anticoagulant therapy in patients with atrial fibrillation depending on the body mass index
by: M. A. Druzhilov, et al.
Published: (2023-06-01)

Hospitalization trends for thromboembolic events in atrial fibrillation: A 12-year national analysis
by: Moises A. Vasquez, et al.
Published: (2025-09-01)

Atrial fibrillation and chronic kidney disease: main clinical characteristics of patients in selected subjects of the Russian Federation
by: M. A. Druzhilov, et al.
Published: (2023-05-01)

Atrial fibrillation in the Americas
by: Jason G. Andrade, et al.
Published: (2025-07-01)

The Role of Atrial Fibrillation and Oral Anticoagulation Status in Health‐Related Quality of Life 12 Months After Ischemic Stroke or TIA
by: Manuel C. Olma, et al.
Published: (2025-01-01)

Modern Anticoagulant Therapy for Atrial Fibrillation: Patient Adherence in Clinical Practice
by: Yu. P. Skirdenko, et al.
Published: (2022-03-01)

Factors determining adherence to anticoagulant therapy in patients with atrial fibrillation
by: D. V. Pevzner, et al.
Published: (2023-06-01)

Efficiency of the Left Atrial Appendage Thrombus Dissolution in Patients with Persistent Nonvalvular Atrial Fibrillation with Warfarin or Direct Oral Anticoagulants Therapy
by: E. S. Mazur, et al.
Published: (2021-11-01)

Ischemic Stroke in Patients Under Oral Anticoagulation: The Achilles Heel of Atrial Fibrillation Management
by: Kyriakos Dimitriadis, et al.
Published: (2025-04-01)

THE OPPORTUNITIES FOR RISK REDUCTION OF RECURRENT STROKE IN ATRIAL FIBRILLATION
by: I. L. Davydkin, et al.
Published: (2015-06-01)

THE EFFICACY OF LONG-TERM WARFARIN THERAPY: THE IMPACT ON THE INCIDENCE OF ISCHEMIC CEREBROVASCULAR DISORDERS AND CLINICAL PREDICTORS OF DEVELOPING SUCH DISORDERS. (Results of a prospective 10-year follow-up study)
by: E. S. KROPACHEVA, et al.
Published: (2017-12-01)

Association Between Oral Anticoagulant Adherence and Serious Clinical Outcomes in Patients With Atrial Fibrillation: A Long‐Term Retrospective Cohort Study
by: Abdollah Safari, et al.
Published: (2024-09-01)

PRACTICAL APPLICATION OF DABIGATRAN ETEXILATE FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION
by: E. D. Kosmacheva, et al.
Published: (2015-09-01)

HOW TO USE DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION
by: S. V. Moiseev
Published: (2015-12-01)

Fibrilação atrial crônica, AVC e anticoagulação: sub-uso de warfarina ? Atrial fibrillation, stroke and anticoagulation: under-use of warfarin?
by: Norberto L. Cabral, et al.
Published: (2004-12-01)

Antithrombotic therapy for atrial fibrillation and comorbidities — how to choose the optimal solution?
by: E V Schlyakhto, et al.
Published: (2022-01-01)

Recurrent ischemic stroke in patients with atrial fibrillation: frequency, heterogeneity, prevention
by: L. A. Geraskina, et al.
Published: (2020-12-01)

Direct Oral Anticoagulants Compared With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease Without Mechanical Valves
by: Ghadeer K. Dawwas, et al.
Published: (2025-02-01)

Efficacy and safety of early anticoagulation in patients with acute ischemic stroke due to atrial fibrillation: a Meta-analysis
by: WANG Yunxiang, et al.
Published: (2024-02-01)

Sex Differences and 2‐Year Mortality in Patients With Atrial Fibrillation Diagnosed After Stroke and Known Atrial Fibrillation: A Register‐Based Study in Sweden
by: Ilham Al Khatib, et al.
Published: (2025-04-01)

Screening and diagnosis of atrial fibrillation using wearable devices
by: Yoon Jung Park, et al.
Published: (2025-01-01)

An Integrated Approach to the Management of a Multimorbid Patient with Atrial Fibrillation from the Standpoint of Modern Guidelines: Rivaroxaban is in Focus
by: V. N. Larina, et al.
Published: (2021-07-01)

Contribution of anticoagulant therapy adherence to the risk of complications of atrial fibrillation
by: Yu. P. Skirdenko, et al.
Published: (2019-03-01)